Paul Knight
Stock Analyst at Keybanc
(1.85)
# 3,219
Out of 5,161 analysts
141
Total ratings
44.44%
Success rate
-2.75%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Maintains: Overweight | $15 → $10 | $3.17 | +215.46% | 8 | Mar 11, 2026 | |
| STVN Stevanato Group | Maintains: Overweight | $37 → $32 | $15.20 | +110.53% | 6 | Mar 5, 2026 | |
| TMO Thermo Fisher Scientific | Upgrades: Overweight | $750 | $488.11 | +53.65% | 7 | Dec 8, 2025 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $325 → $350 | $238.25 | +46.90% | 12 | Oct 24, 2025 | |
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $6.81 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $132.02 | +66.64% | 1 | Sep 4, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $7.85 | +91.08% | 9 | Aug 6, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $0.52 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $52.75 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $297.54 | +54.60% | 5 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $0.97 | - | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $3.39 | +135.99% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $87.83 | +65.09% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $162.30 | +158.78% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $100.69 | +128.42% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $19.01 | +73.59% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $26.16 | +37.61% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $195.06 | +58.93% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $118.84 | +85.12% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.51 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $2.69 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $113.29 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $22.87 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $8.44 | +373.93% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $168.91 | +77.61% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $168.11 | +48.71% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $111.75 | +294.63% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $133.43 | +76.87% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $73.75 | +34.24% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $13.40 | +310.45% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $32.00 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $80.60 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $121.50 | - | 5 | Oct 23, 2017 |
Exagen
Mar 11, 2026
Maintains: Overweight
Price Target: $15 → $10
Current: $3.17
Upside: +215.46%
Stevanato Group
Mar 5, 2026
Maintains: Overweight
Price Target: $37 → $32
Current: $15.20
Upside: +110.53%
Thermo Fisher Scientific
Dec 8, 2025
Upgrades: Overweight
Price Target: $750
Current: $488.11
Upside: +53.65%
West Pharmaceutical Services
Oct 24, 2025
Maintains: Overweight
Price Target: $325 → $350
Current: $238.25
Upside: +46.90%
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $6.81
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $132.02
Upside: +66.64%
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $7.85
Upside: +91.08%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.52
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $52.75
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $297.54
Upside: +54.60%
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.97
Upside: -
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $3.39
Upside: +135.99%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $87.83
Upside: +65.09%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $162.30
Upside: +158.78%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $100.69
Upside: +128.42%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $19.01
Upside: +73.59%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $26.16
Upside: +37.61%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $195.06
Upside: +58.93%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $118.84
Upside: +85.12%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $3.51
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $2.69
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $113.29
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $22.87
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $8.44
Upside: +373.93%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $168.91
Upside: +77.61%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $168.11
Upside: +48.71%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $111.75
Upside: +294.63%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $133.43
Upside: +76.87%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $73.75
Upside: +34.24%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $13.40
Upside: +310.45%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $32.00
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $80.60
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $121.50
Upside: -